We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
-9.31%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$58.5M
AUM Growth
-$9.48M
Cap. Flow
-$2.97M
Cap. Flow %
-5.08%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EVLV icon
Evolv Technologies
EVLV
+$2.91M
2
ROIV icon
Roivant Sciences
ROIV
+$58.6K

Sector Composition

Rank Sector Weight
1 Industrials 56.17%
2 Healthcare 43.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLV icon
1
Evolv Technologies
EVLV
$943M
$32.9M 56.17%
4,590,000
-410,000
-8% -$2.91M
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.57B
$24.3M 41.53%
5,941,120
DFTX
3
Definium Therapeutics
DFTX
$5.73B
$1.34M 2.3%
100,350
ROIV icon
4
Roivant Sciences
ROIV
$25.2B
-3,875
Closed -$58.6K

Similar funds

Data Collective IV's Q4 2025 Portfolio in Review

As of Q4 2025, Data Collective IV held 4 positions worth $58.5M, down 14% from $68M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Data Collective IV withdrew a net $2.97M in Q4 2025, closing 1 position and reducing 1 holding. Its most notable exit was Roivant Sciences, an estimated $58.6K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 56% of assets, up from 56% a quarter earlier, followed by Healthcare.

  • Data Collective IV's biggest Q4 2025 reduction was Evolv Technologies, cutting an estimated $2.91M.
  • Data Collective IV fully exited Roivant Sciences in Q4 2025, selling an estimated $58.6K.
  • Data Collective IV's ten largest holdings make up 100% of its $58.5M portfolio in Q4 2025.
  • Data Collective IV opened 0 new positions and closed 1 in Q4 2025.
  • Data Collective IV's portfolio value fell 14% quarter-over-quarter to $58.5M.

Based on Data Collective IV's 13F filing for Q4 2025, filed 17 Feb 2026.